MITOCHONDRIAL COMPLEX III DEFICIENCY (disorder)
|
0.530 |
GeneticVariation
|
disease |
BEFREE |
Novel Homozygous Variant in TTC19 Causing Mitochondrial Complex III Deficiency with Recurrent Stroke-Like Episodes: Expanding the Phenotype.
|
29961508 |
2018 |
MITOCHONDRIAL COMPLEX III DEFICIENCY (disorder)
|
0.530 |
GeneticVariation
|
disease |
BEFREE |
Mutations in TTC19 cause mitochondrial complex III deficiency and neurological impairment in humans and flies.
|
21278747 |
2011 |
MITOCHONDRIAL COMPLEX III DEFICIENCY (disorder)
|
0.530 |
GeneticVariation
|
disease |
BEFREE |
Phenotypic variation of TTC19-deficient mitochondrial complex III deficiency: a case report and literature review.
|
25899669 |
2015 |
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2
|
0.400 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
nervous system disorder
|
0.310 |
GeneticVariation
|
group |
BEFREE |
TTC19 mutations constitute a rare cause of CIII deficiency and are associated with neurological disorders in childhood and adulthood.
|
25652355 |
2015 |
Paraparesis, Spastic
|
0.110 |
GeneticVariation
|
phenotype |
BEFREE |
A Japanese case of cerebellar ataxia, spastic paraparesis and deep sensory impairment associated with a novel homozygous TTC19 mutation.
|
25652355 |
2015 |
Body mass index
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Body mass index
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry.
|
30239722 |
2019 |
Ubiquinone dehydrogenase deficiency
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
We reviewed the phenotypes and genotypes of all 11 patients with TTC19 mutations leading to complex III deficiency (including our case).
|
25899669 |
2015 |
Ubiquinone dehydrogenase deficiency
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Loss-of-function mutations in TTC19 (tetra-tricopeptide repeat domain 19) have been associated with severe neurological phenotypes and mitochondrial respiratory chain complex III deficiency.
|
28673544 |
2017 |
Ubiquinone dehydrogenase deficiency
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Novel TTC19 mutation in a family with severe psychiatric manifestations and complex III deficiency.
|
23532514 |
2013 |
Encephalopathies
|
0.020 |
GeneticVariation
|
group |
BEFREE |
We identified a homozygous nonsense mutation in the gene encoding tetratricopeptide 19 (TTC19) in individuals from two families affected by progressive encephalopathy associated with profound cIII deficiency and accumulation of cIII-specific assembly intermediates.
|
21278747 |
2011 |
Cerebellar Ataxia
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
A Japanese case of cerebellar ataxia, spastic paraparesis and deep sensory impairment associated with a novel homozygous TTC19 mutation.
|
25652355 |
2015 |
Failure to Thrive
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The bilateral retinal cherry red spots and failure to thrive observed in our patient are unique features, which have not been described, in previously reported patients with TTC19 mutations.
|
25899669 |
2015 |
Cerebrovascular accident
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Novel Homozygous Variant in TTC19 Causing Mitochondrial Complex III Deficiency with Recurrent Stroke-Like Episodes: Expanding the Phenotype.
|
29961508 |
2018 |
Ataxia, Spinocerebellar
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Exome sequencing reveals a novel TTC19 mutation in an autosomal recessive spinocerebellar ataxia patient.
|
24397319 |
2014 |
Mitochondrial Encephalomyopathies
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Our findings add to the array of mutations in TTC19, corroborate the notion of genotype/phenotype variability in mitochondrial encephalomyopathies even within a single family, and indicate that psychiatric manifestations are a further presentation of low CIII.
|
23532514 |
2013 |
Global developmental delay
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We performed exome sequencing and selective mutational analysis of TTC19, respectively, in patients from three unrelated families presenting with initially unspecific clinical signs of muscular hypotonia and global developmental delay followed by regression, ataxia, loss of speech, and rapid neurological deterioration.
|
25887401 |
2015 |
Pediatric failure to thrive
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The bilateral retinal cherry red spots and failure to thrive observed in our patient are unique features, which have not been described, in previously reported patients with TTC19 mutations.
|
25899669 |
2015 |
Failure to thrive in infant
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The bilateral retinal cherry red spots and failure to thrive observed in our patient are unique features, which have not been described, in previously reported patients with TTC19 mutations.
|
25899669 |
2015 |
MITOCHONDRIAL COMPLEX III DEFICIENCY (disorder)
|
0.530 |
Biomarker
|
disease |
CTD_human |
|
|
|
MITOCHONDRIAL COMPLEX III DEFICIENCY (disorder)
|
0.530 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
MITOCHONDRIAL COMPLEX III DEFICIENCY (disorder)
|
0.530 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2
|
0.400 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2
|
0.400 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in TTC19 cause mitochondrial complex III deficiency and neurological impairment in humans and flies.
|
21278747 |
2011 |